James E Rothman

Professor Rothman is the Sterling Professor and Chair of the Department of Cell Biology at Yale University School of Medicine. He also serves as the Chair of Arsenal Capital’s Healthcare Advisory Board. Prior to joining the faculty at Yale in 2008, he served as Chief Scientist of General Electric Healthcare and its predecessor, Amersham. Dr. Rothman also served at various times as an advisor to top research management at Genentech, Merck & Co., J&J, GlaxoSmithKline, and Eli Lilly.

He previously has been a professor at Stanford, Princeton, and Columbia Universities and at Memorial Sloan-Kettering Cancer Center, where he served as Vice-Chairman of the Sloan-Kettering Institute. In 2013 Dr. Rothman was awarded a Nobel Prize in Physiology or Medicine and in 2002 he received the Albert Lasker Basic Medical Research Award.